A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

There is no fulltext present in this item.

Title:	A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma
Author(s):	Liu, Xiaoyan; Swen, J.J.; Diekstra, M.H.M.; Boven, Epie; Castellano, D.; Gelderblom, Hans; Vermeulen, S.H. ; Oosterwijk, E. ; Kiemeney, L.A.L.M. ; Rini, Brian I.; Guchelaar, H.J.
Publication year:	2018
Source:	Clinical Cancer Research, vol. 24, iss. 10, (2018), pp. 2350-2356
ISSN:	1078-0432
DOI:	https://doi.org/10.1158/1078-0432.CCR-17-2815
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/191550
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Human Genetics Health Evidence Urology
Journal title:	Clinical Cancer Research
Volume:	vol. 24
Issue:	iss. 10
Page start:	p. 2350
Page end:	p. 2356